Bristol Myers Squibb (BMY) Change in Receivables (2009 - 2026)
Bristol Myers Squibb (BMY) posted Change in Receivables of $1.18 billion for Q2 2026, up 144.4% from $484 million a year earlier.
Powered by 
Analysis
Bristol Myers Squibb (BMY) Change in Receivables (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Receivables at Bristol Myers Squibb was -$678 million; for FY2025, it was $295 million.
- Annual Change in Receivables shows a five-year compound annual growth rate of -14.5% (FY2020 to FY2025).
- In prior years, Bristol Myers Squibb's Change in Receivables was -$264 million in FY2024, $995 million in FY2023 (+50.1%), $663 million in FY2022 (-37.1%) and $1.05 billion in FY2021 (+63.2%).
- The Q2 2026 figure stands as the highest quarterly Change in Receivables in data going back to Q3 2009.
- The strongest year-over-year quarter for Change in Receivables in the past five years was Q4 2023, with growth of 379.2%; the weakest was Q2 2023, with a decline of 90.3%.
- According to Business Quant data, Change in Receivables for the three prior quarters was -$1.69 billion (Q1 2026), -$19 million (Q4 2025) and -$155 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 1.35 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 1.37 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | - |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.09 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 333.00 Mn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | - |
| 10 | Bristol Myers Squibb | 126.07 Bn | 77.35 Bn | 9.25 Bn | 1.18 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.18 Bn |
| Mar 31, 2026 | -1.69 Bn |
| Dec 31, 2025 | -19.00 Mn |
| Sep 30, 2025 | -155.00 Mn |
| Jun 30, 2025 | 484.00 Mn |
| Mar 31, 2025 | -15.00 Mn |
| Dec 31, 2024 | -143.00 Mn |
| Sep 30, 2024 | -661.00 Mn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | -479.00 Mn |
| Dec 31, 2023 | 508.00 Mn |
| Sep 30, 2023 | 247.00 Mn |
| Jun 30, 2023 | 65.00 Mn |
| Mar 31, 2023 | 175.00 Mn |
| Dec 31, 2022 | 106.00 Mn |
| Sep 30, 2022 | 674.00 Mn |
| Jun 30, 2022 | 669.00 Mn |
| Mar 31, 2022 | -786.00 Mn |
| Dec 31, 2021 | 168.00 Mn |
| Sep 30, 2021 | 260.00 Mn |
API Access
Bristol Myers Squibb Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=BMY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();